- Developers
- Learn how AI is applied to biological data for predictive health, potentially inspiring new applications.
- Business
- Understand how AI and biotech are converging to create new healthcare markets and predictive diagnostics.
- Everyday users
- Discover how AI might soon help predict and prevent serious illnesses like cancer and diabetes.
This interview features a CEO discussing a novel application of AI in predictive health and longevity.
#291 Naveen Jain: How AI Predicts Cancer, Diabetes & Chronic Illness
Audio streams from Craig S. Smith. Your place is remembered on this device.
From Subvolts
Summary and analysis by Subvolts editorial, AI-assisted.
Eye on AI host Craig S. Smith interviews Naveen Jain, CEO of Viome, about using RNA sequencing and AI to predict chronic illnesses. Jain explains how Viome analyzes microbiome and human gene expression to detect diseases like cancer and diabetes before symptoms appear. The discussion covers RNA's advantage over DNA for health indication and the role of large molecular AI models in early detection.
This episode explains how computers can now look at tiny biological signals, like RNA, to guess if you might get sick with things like cancer or diabetes, even before you feel it. It's like a super early warning system for your health.
This episode offers insights into how AI is moving beyond language and image tasks into complex biological prediction. Listeners will learn about Viome's approach to digitizing the human body and predicting disease using RNA and AI. It's for anyone interested in the future of health tech and longevity. This work parallels frontier labs' efforts in applying large models to scientific discovery, though Viome focuses on a specific health application.
- HostCraig S. Smith
- GuestNaveen Jainfounder and CEO, Viome
- Guest: Naveen Jain, founder and CEO of Viome
- Show: Eye on AI
- Episode Title: Naveen Jain: How AI Predicts Cancer, Diabetes & Chronic Illness
- Length: 53 minutes
- Company Mission: Digitize the human body, predict illness before symptoms appear, and revolutionize healthcare
- Technology Used: RNA sequencing, metatranscriptomics, large molecular AI models
This episode is sponsored by AGNTCY. Unlock agents at scale with an open Internet of Agents. Visit https://agntcy.org/ and add your support. Can AI and RNA testing make illness optional? In this episode, Eye on AI host Craig S. Smith sits down with Naveen Jain, founder and CEO of Viome, to explore how RNA sequencing and artificial intelligence are transforming our understanding of chronic disease. Jain shares how a personal tragedy led him to launch Viome, a company on a mission to digitize the human body, predict illness before symptoms appear, and revolutionize healthcare. Together they discuss how Viome uses metatranscriptomics to analyze microbiome and human gene expression, what makes RNA a better indicator of health than DNA, and how large molecular AI models are paving the way for early detection of cancer, diabetes, Alzheimer's, and more. Jain also reveals his bold entrepreneurial framework—"Why this, why now, why me?"—and his belief that asking better questions is the real key to innovation. If you're interested in the intersection of AI, biotechnology, and human longevity, this is an episode you won't want to miss. Stay Updated: Craig Smith on X:https://x.com/craigss Eye on A.I. on X: https://x.com/EyeOn_AI
- metatranscriptomics
- Naveen Jain
- a way to study all the RNA molecules in a biological sample, showing what genes are active
- RNA sequencing
- Naveen Jain
- a method to read out the genetic instructions from RNA, showing which genes are being used by cells
- large molecular AI models
- Naveen Jain
- advanced AI systems trained on vast amounts of biological data to understand complex molecular interactions
Ukraine's Secret Weapon: The Points System Winning the Drone War | Andrii Hrytseniuk
WithAndrii Hrytseniuk
Same guests, other shows
Our Updated AGI Timeline, 57% Job Automation Risk, and Solving the US Debt Crisis w/ Naveen Jain, Salim Ismail & Alexander Wisner-Gross | EP #212
WithNaveen Jain, Salim Ismail, Alexander Wissner-Gross
Questions people ask
- How does Viome predict illness?
- Viome uses metatranscriptomics to analyze microbiome and human gene expression through RNA sequencing. This data, processed by large molecular AI models, helps predict illnesses like cancer and diabetes before symptoms appear.
- Why is RNA testing better than DNA testing for health?
- The episode suggests RNA is a better indicator of current health status and biological activity compared to DNA, which represents a more static genetic blueprint.
Page generated Oct 19, 2026. Summaries are Subvolts' own; the audio, artwork and notes belong to Craig S. Smith.


